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Abstract
The regulation of cell morphology is a dynamic process under the control of multiple protein complexes acting in a
coordinated manner. Phosphoinositide 3-kinases (PI3K) and their lipid products are widely involved in cytoskeletal
regulation by interacting with proteins regulating RhoGTPases. Class II PI3K isoforms have been implicated in the regulation
of the actin cytoskeleton, although their exact role and mechanism of action remain to be established. In this report, we
have identified Dbl, a Rho family guanine nucleotide exchange factor (RhoGEF) as an interaction partner of PI3KC2b. Dbl
was co-immunoprecipitated with PI3KC2b in NIH3T3 cells and cancer cell lines. Over-expression of Class II phosphoinositide
3-kinase PI3KC2b in NIH3T3 fibroblasts led to increased stress fibres formation and cell spreading. Accordingly, we found
high basal RhoA activity and increased serum response factor (SRF) activation downstream of RhoA upon serum stimulation.
In contrast, the dominant-negative form of PI3KC2b strongly reduced cell spreading and stress fibres formation, as well as
SRF response. Platelet-derived growth factor (PDGF) stimulation of wild-type PI3KC2b over-expressing NIH3T3 cells strongly
increased Rac and c-Jun N-terminal kinase (JNK) activation, but failed to show similar effect in the cells with the dominant-
negative enzyme. Interestingly, epidermal growth factor (EGF) and PDGF stimulation led to increased extracellular signal-
regulated kinase (Erk) and Akt pathway activation in cells with elevated wild-type PI3KC2b expression. Furthermore,
increased expression of PI3KC2b protected NIH3T3 from detachment-dependent death (anoikis) in a RhoA-dependent
manner. Taken together, these findings suggest that PI3KC2b modulates the cell morphology and survival through a
specific interaction with Dbl and the activation of RhoA.
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Introduction
The phosphoinositide-3 kinase (PI3K) family comprises evolu-
tionary conserved lipid kinases characterised by their ability to
phosphorylate phosphoinositides at the D-3 position of the inositol
ring. This reaction leads to the production of essential for the cell
second messengers as PI(3)P, PI(3,4)P2 and PI(3,4,5)P3 [1]. The
subsequent membrane recruitment of enzymes recognizing and
binding D-3 phosphorylated phosphoinositides leads to their
activation, which results in the initiation of multiple signalling
cascades providing growth, survival and motility signals to the cell.
The biological functions of PI3K have been widely investigated by
the use of transgenic mouse models and in vitro cell systems. It
became clear that PI3K are extremely important for cell
proliferation, differentiation, chemotaxis and motility. Further-
more, they are implicated in the embryonic development,
immunity and the development of diseases such as cancer,
inflammation and diabetes [1–3]. The family of PI3K comprises
three classes, based on structural similarity and in vitro substrate
specificity. Class I PI3K is divided into Class IA, comprising three
isoforms activated by growth factor receptor tyrosine kinases
(RTKs) and Class IB with a single member activated by the
Gbcsubunit downstream of activated G-protein coupled receptors
(GPCR) [1]. The main product of Class I PI3K activity, the lipid
second messenger PI(3,4,5)P3, activates a plethora of downstream
molecules by binding to their pleckstrin-homology (PH) domains
[4]. To one of the best studied effectors belong the serine/
threonine kinase Akt [5] and RhoGEFs [6].
Class II PI3K consists of three members termed PI3KC2a,
PI3KC2b and PI3KC2c. In vitro, the main substrates of these
enzymes are PI and PI(4)P [7,8]. Class II PI3K are activated
downstream of RTK (EGFR, PDGFR and Kit), cytokine
receptors, insulin and integrins [9–13]. Localisation of PI3KC2a
in the trans-Golgi apparatus and in clathrin vesicles indicates
function in clathrin assembly and clathrin mediated trafficking
[14,15]. Further studies have revealed that PI3KC2b is implicated
in the cytoskeletal regulation and migration of cancer cells [16–
18]. However, the specific functions of Class II PI3K in response
to their activators remain to be fully understood.
The control of actin filaments dynamic is crucial for cell
morphology, adhesion and movement [19]. PI3Ks regulate cell
polarity and motility by controlling multiple proteins and protein
complexes implicated in cytoskeletal rearrangement and actin
dynamics [20]. It was recently demonstrated in Drosophila
melanogaster hemocytes that Pi3K68D in collaboration with
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endosomal myotubularin PI3K phosphatase Mtm-1 coregulates
the PI(3)P pool, which in turn promotes F-actin reorganization
and modulates protrusion formation [21]. D. melanogaster Pi3K68D
is a homologue of human PI3KC2b and human Mtm genes
present high functional conservation with the D. melanogaster MTM
family members, which suggests that the MTM/Class II PI3K
pathway might be important for similar biological responses in
mammalian cells [21]. However, the main players in the
regulation of actin dynamics are GTP-binding proteins known
as RhoGTPases. A recent report in vascular smooth muscle cells of
spontaneously hypertensive rats showed that Class II PI3KC2a is
involved in Ca2+-induced Rho signaling pathway activation, which
stimulates the interaction of myosin II (MII) with actin filaments,
which in turn leads to increased cell contractility [22]. RhoGT-
Pases proteins cycle between inactive GDP- and active GTP-
bound states and hydrolyse GTP to GDP. This process is tightly
regulated by guanine nucleotide exchange factors (GEFs),
GTPase-activating proteins (GAPs) and guanine nucleotide
dissociation inhibitors (GDIs). The best studied Rho GTPases
under the control of PI3K activity are RhoA, Rac1 and Cdc42
[23]. Rac1 is involved in the formation of membrane extensions
(lamellipodia or ruffles) along the leading edge of the cell. Cdc42
controls the formation of spike-like membrane extensions (filopo-
dia), involved in the recognition of the extracellular environment.
RhoA stabilises the cell body and promotes cell attachment to the
extracellular matrix by inducing the formation of stress fibres and
focal adhesions [24]. Ligand binding to RTK, integrins and
GPCR results in PI3K activation and accumulation of PI(3,4)P2
and PI(3,4,5)P3 in the cell membrane. This process is spatially
defined by the site of ligand concentration and results in the local
membrane recruitment of GEFs [25]. The dbl oncogene was the
first GEF identified by cloning from human diffuse B-cell
lymphoma and subsequently from nodular poorly differentiated
lymphoma (NPDL), which upon transfection into NIH3T3 cells
induced cellular transformation [26,27]. The oncogenic form of
dbl arises from full length dbl as a result of amino acid truncation of
its N-terminus, which is crucial for the increased transforming
activity of dbl oncogene [28,29]. The mechanism of proto-Dbl
regulation is strongly dependent on its multi-domain structure. As
many other GEFs family members, it contains Dbl homology-
Pleckstrin homology (DH-PH) tandem domains. These domains
are respectively responsible for the intrinsic GEF catalytic activity
toward RhoGTPases and the intracellular distribution to the
plasma membrane or to the cytoskeletal matrix [30–32]. The
spectrin domain of proto-Dbl located at the N-terminus regulates
Dbl activity by indirect binding to its PH-domain, thus blocking
the access to the catalytic DH domain and masking the
intracellular targeting function of the PH domain [31–33]. Many
GEFs exist in an inactive or partially active state maintained by
complex intra- and intermolecular interactions. These inhibitory
conformations can be altered by upstream regulatory signals,
which involve phosphorylation, oligomerization, interactions with
heterotrimeric G-protein subunits, protein kinases, adaptor or
scaffolding proteins, or phosphoinositol lipids, and result in
intracellular translocation and stimulation of the GEF catalytic
activity [34–36]. Once GEFs are at the membrane, they assemble
into multi-protein complexes with PI3K, RhoGTPases and actin-
binding proteins [37]. These multi-protein complexes are crucial
for the proper localisation to dynamic actin structures and the
efficient activation of RhoGTPases [37,38].
In our previous study, we reported the implication of PI3KC2b
in a multi-protein complex regulating Rac activity in A-431
epithelial carcinoma cells [17]. In order to investigate the function
of PI3KC2b in non-tumor cells, we established clones of NIH3T3
fibroblast stably expressing either the wild-type or dominant-
negative form of the enzyme. According to our previous data, we
found elevated Rac/JNK activation upon PDGF stimulation in
PI3KC2b wild-type expressing cells. We further observed
increased cell spreading and strong stress fibres formation due to
elevated RhoA activity. We show that serum stimulation leads to
strong serum response factor (SRF) induction downstream of
RhoA and polymerised actin. This finding led us to the
identification of a RhoGEF Dbl as interaction partner of
PI3KC2b. Hence, we hypothesise that in NIH3T3 cells PI3KC2b
is involved in a complex comprising Dbl and regulates RhoA and
Rac1 activity. This signalling cascade further protected the cells
from detachment-induced apoptosis.
Materials and Methods
Reagents and Antibodies
The following antibodies were used: PI3KC2b was described in
[7], 9E10 myc epitope, p115RhoGEF, Dbl, Caveolin-2, Grb2,
Src, RhoA, GFP, p53 (Santa Cruz Biotechnology, Santa Cruz,
CA, USA); Caveolin-1, Akt (pan), phospho-Akt (Ser473), phospho-
Akt (Thr308), phospho-SAPK/JNK (Thr183/Tyr185), phospho-
S6 ribosomal protein (Ser240/244), phospho-GSK-3a/b (Ser21/
9), phospho-FOXO1 (Thr24)/FOXO3a (Thr32), phospho-Erk1/
2 (Thr202/Tyr204), p44/42 MAPK, Bcl-2, Bcl-XL, PTEN,
phospho-Bad (Ser136) (Cell Signalling Technology, Danvers,
MA, USA); FITC-conjugated anti-mouse and anti-rabbit anti-
bodies, b-actin, anti-mouse IgG (Sigma-Aldrich, St Louis, MO,
USA); anti-rabbit-IgG (R&d Systems, Minneapolis, MN,USA);
Rac1 (BD Transduction Laboratories, USA). Anti-EE antibody
was kindly provided by Julian Downward (CRUK). Alexa Fluor
555 was obtained from Invitrogen. Recombinant EGF, PDGF BB
were purchased from Calbiochem, La Jolla,CA,USA. Oleoyl-L-a-
lysophosphatidic acid (LPA) was purchased from Sigmla-Aldrich,
St Louis, MO, USA.
The SRF luciferase reporter plasmid p3DA-Luc has been
described previously [39].
Cell Culture
Mouse NIH3T3 fibroblast, HEK293 and COS-1 cells were
purchased from the American Type Culture Collection. Mouse
NIH3T3 fibroblast, HEK293 and COS-1 cells were grown in
DMEM (Life Technologies/Invitrogen) supplemented with 10%
(v/v) FCS and penicillin/streptomycin/L-glutamine, and passaged
every 3 to 5 days by trypsinization. Cultures were incubated in a
humidified atmosphere of 5% CO2 at 37uC. Stably transfected
NIH3T3 clones were grown in the presence of 0.8 mg/ml G418.
Retroviral Infection
NIH3T3 cell lines stably expressing Glu-tagged PI3KC2b wild-
type (WT) were described [9]. The cDNA construct encoding
myc-tagged dominant-negative kinase-dead PI3K-C2b (DN) [17]
was subcloned into the pBabe Neo Vector. Retroviral packaging
BOSC 23 cells were transfected using a Ca2+ phosphate protocol.
NIH3T3 cells were grown up to 40–60% confluence and infected
with the recombinant retrovirus for 48 h at 37uC. The cultures
were split 1:10 in DMEM- 10% FCS and 0.8 mg/ml G418
containing medium. Colonies of resistant cells appeared after 1
week. Single colonies were picked and expanded in selective
medium. Protein expression was confirmed by western blot
analysis. All experiments were done with at least two clones from
each transfection. Cells transduced with pBabe Neo vector without
insert were used as controls.
Role of PI3KC2b in RhoA Activation
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Transient Transfections
HEK293 cells were transiently transfected with a Ca2+
phosphate protocol [7], while NIH3T3 and COS-1 cells were
transfected with Lipofectamine or Lipofectamine 2000 (Invitrogen)
respectively, according to the manufacturer’s instructions.
Growth Factor Stimulations
To investigate Erk and Akt signalling downstream of EGFR and
PDGFR in NIH3T3 cells stably expressing PI3KC2b wild-type
(WT) and dominant-negative (DN) were grown to confluency in a
six-well plate and starved overnight in DMEM containing 0.5%
FCS and penicillin/streptomycin/L-glutamine. Cells were then
stimulated with the EGF (1 nM) and PDGF (1 nM) for 10 min. at
37uC, as indicated in the figure legends. Cellular lysates were
prepared as described below.
Stimulation of cells with PDGF and LPA for investigation of
RhoA and Rac1 activity is described below in the section of
RhoGTPases activation assay.
SDS/PAGE and Western-blot Analysis
NIH3T3-C2b-WT and –DN cellular lysates were prepared with
RIPA buffer (50 mM Tris.Cl pH 7.4, 150 mM NaCl, 1 mM
EDTA, 1% Triton X-100, 1% sodium deoxycholate, 0.1% SDS,
10% glycerol, 10 mM leupeptin, 10 mM pepstatin A, 1 mM
phenylmethylsulfonylfluorid [PMSF], 5 mM iodoacetamide,
5 mM benzamidine, 2 mM sodium orthovanadate [http://en.
wikipedia.org/wiki/Chemical_formulaNa3VO4] and 10 mM so-
dium fluoride [NaF]). In the case of NIH3T3, COS1 and
HEK293 cells lysis buffer was changed to Triton 1% (50 mM
Tris.Cl pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.5 mM EGTA,
1% Triton X-100, 0.5% NP-40) supplemented with 76concen-
trated stock of protease inhibitors (Complete Mini, Roche) and
phosphatase inhibitors (1 mM NaF, 1 mM Na3VO4, 10 mM b-
glycerophosphate). For the studies of endogenous complex
formation in IMR5 cells Triton 0.5% and Brij96 1% (50 mM
Tris.Cl pH 7.4, 150 mM NaCl, 1 mM EDTA, 0.5 mM EGTA,
1% Brij96) lysis buffers supplemented with 76concentrated stock
of protease inhibitors (Complete Mini, Roche) and phosphatase
inhibitors (1 mM NaF, 1 mM Na3VO4, 10 mM b-glycerophos-
phate) were used, as indicated in the figure legends. Prior to lysis
cells were washed once with ice-cold phosphate-buffered saline
(PBS), lysed on ice for 20 min., and centrifuged at 16,0006g for
25 min. at 4uC. The supernatants were collected and normalized
for protein content by using the BCA (bicinchoninic acid) protein
assay kit (Pierce). 2x or 5x SDS sample buffer (50 mM Tris.HCl,
pH 6.8, 2%/5% SDS, 10% glycerol, 200 mM DTT, and 0.25%
bromophenol blue) was then added to the samples, followed by
denaturation for 3 min. at 100uC and analysed by SDS/PAGE.
The gels were transferred to a hydrophobic PVDF membrane
(Hybond-P; Amersham Biosciences) by electrophoresis. The
membranes were then blocked in 16 PBS, 5% (w/v) BSA
(phospho-specific antibodies) or 16PBS/3% non-fat dry milk (all
other antibodies) for 16 h at 4uC. The membranes were incubated
with primary antibodies (diluted according to the manufacturer’s
protocol) for 16 h at 4uC. After washing in 16PBS and 0.1% (w/
v) Tween 20, the immunoblots were incubated with donkey anti-
rabbit IgG or sheep anti-mouse IgG secondary antibodies
(1:10000 dilution) coupled with horseradish peroxidase (Amer-
Figure 1. PI3KC2b interacts with Dbl GEF for Rho GTPases. (A)
Lysates of NIH3T3 cells stably overexpressing wild-type Glu-PI3KC2b
(NIH3T3-C2b-WT) were immunoprecipitated (IP) with an anti-C2b, anti-
Glu (EE) tag, anti-Dbl or control IgG antibody. PI3KC2b interaction with
the endogenous Dbl, as well as Grb2 and Src was detected by
immunoblotting (IB) with the indicated antibodies. (B) Complex of
endogenous PI3KC2b and Dbl was immunoprecipitated from the whole
cell extract (WCE) of the parental NIH3T3 cells and IMR5 neuroblastoma
human cancer cells with anti-Dbl, anti-C2b and control IgG antibody.
Samples were subjected to western blot analysis with the indicated
antibodies. In the case of IMR5 cells Triton 0.5% and Brij96 1% lysis
buffers were used, while NIH3T3 cells were lysed with Triton 1%.
Asterisk indicates PI3KC2b. (C) Interaction between the PI3KC2b and Dbl
was examined by the pull-down (PD) of PI3KC2b GST-fused N-terminal
and C2 C-terminal domains in HEK293 cells transfected with HA-proto-
Dbl (Dbl), pcDNA3 empty vector (V) or untransfected control (-).
Complex formation was shown by immunoblotting with anti-Dbl
antibody. Asterisk indicates ectopically expressed (HA-tag) Dbl. (D)
Interaction between the Dbl and Grb2 was examined by the GST-Grb2
pull-down in HA-proto-Dbl (Dbl) transfected and untransfected (-)
HEK293 cells. Pull-down samples were subjected to western blot
analysis with indicated antibodies. All experiments were repeated at
least two times with similar results.
doi:10.1371/journal.pone.0044945.g001
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sham Biosciences) for 1 h at room temperature. After washing of
the immunoblots, chemiluminescence was used for detection,
using either the ECLH (enhanced chemiluminescence) western
blotting detection reagents (Amersham Biosciences) or Super-
Signal West Femto Maximum Sensitivity Substrate (PIERCE)
according to the manufacturer’s protocol.
Immunoprecipitations
NIH3T3-C2b-WT, NIH3T3 parental and IMR5 cells were
grown to confluence in 10-cm dishes, washed with ice cold
phosphate-buffered saline (PBS) before lysis on ice for 20 min. in
0.5–1 ml of lysis buffer (as indicated in the previous section).
Insoluble material was removed by centrifugation for 30 min. at
16,0006g in 4uC. Immunoprecipitation was performed for 2 h at
4uC with primary antibodies (diluted according to the manufac-
turer’s instructions). IP Matrix (ExactaCruz, Santa Cruz Biotech-
nology) or Protein A- or G-Sepharose 4 Fast Flow beads (GE
Healtcare) were then added, and the incubation was continued for
1 h at 4uC. The immunoprecipitates were washed three times in
the lysis buffer and resuspended in 2x SDS sample buffer (50 mM
Tris.HCl, pH 6.8, 2% SDS, 10% glycerol, 200 mM DTT, and
0.25% bromophenol blue). Samples were denatured for 3 min. at
100uC and analysed by SDS/PAGE and western blot.
Production of GST-Fusion Proteins
pGEX-2T expression vectors encoding GST-PAK-CRIB,
GST-rhotekin, GST-RhoA, GST-Grb2, GST-PI3KC2b N-termi-
nal and C2 C-terminal domains were transformed into Escherichia
coli BL21 cells. The incubation proceeded at 37uC until OD600
reached 0.5. Protein expression was induced with 0.2 mM
isopropyl-b-D-thiogalactopyranoside (IPTG) and incubated at
30uC for 3–4 h. The bacteria were collected by centrifugation
and resuspended in lysis buffer (50 mM Tris-HCl pH 7.5, 1%
Triton X-100, 150 mM NaCl, 5 mMMgCl2, 1 mM DTT, 10 mM
leupeptin, 10 mM pepstatin and 1 mM PMSF). In the case of
GST-Grb2, GST-PI3KC2b N-terminal and C2 C-terminal
domains lysis buffer was changed to: 50 mM Tris HCl pH 7.5,
150 mM NaCl, 5 mM EDTA pH 8.0, 1% Triton supplemented
with 76concentrated stock of protease inhibitors (Complete Mini,
Roche), 1 mM PMSF, 10 mM leupeptin, 10 mM pepstatin, 5 mM
benzamidin, 1 mM DTT, 1 ml/ml aprotinin, 1 mM NaF and 1
mM Na3VO4. Bacteria were thereafter sonicated on ice six times
for 10 s or 3 times for 45 sec with 1 min. intervals (in the case of
GST-Grb2, GST-PI3KC2b N-terminal and C2 C-terminal
domains). The lysed cells were clarified by centrifugation at
30,0006g for 30 min. at 4uC. GST-fusion proteins were affinity-
purified from the resulting supernatants by addition of glutathione-
sepharose beads (Amersham Biosciences) followed by incubation
at 4uC for 60 min. The glutathione-sepharose beads were
collected by centrifugation at 8056g at 4uC followed by four
washes with washing buffer (50 mM Tris-HCl pH 7.5, 0.5%
Triton X-100, 150 mM NaCl, 5 mMMgCl2, 1 mM DTT, 10 mM
leupeptin, and 0.1 mM PMSF. After the final wash, the beads
containing the GST-fusion proteins were resuspended in the
washing buffer supplemented with 10% glycerol. The purity of the
GST-fusion proteins was assayed by SDS-PAGE.
GST-tagged NT-, spectrin-, onco- and PH- Dbl mutant
constructs, described previously in [31], were expressed in COS-
1 cells, lysed with HEPES buffer as in [31] and purified with
glutathione-sepharose beads (GE Healthcare). Beads containing
the GST-fusion proteins were washed 3–46with ice-cold HEPES
buffer and 2x with washing buffer (50 mM Tris pH 7.5, 150 mM
NaCl). Next, they were resuspended in the washing buffer
supplemented with 1 mM DTT and 50% glycerol and stored in
220uC.
Figure 2. PI3KC2b binds with high affinity to the spectrin- and PH- Dbl domain. (A) Schematic representation of Dbl mutant constructs,
which were kind gift of Prof. Danny Manor from the School of Medicine at Case Western Reserve University, Cleveland, USA. (B) COS-1 cells co-
transfected with Myc-PI3KC2b and different GST-fused Dbl domains (N-, spectrin-, onco-, PH-) in pEBG vector were subjected to gluthatione-
sepharose beads affinity-purification and immunobotted with indicated antibodies. Experiment was repeated at least two times with similar results.
PC – positive control; COS-1 cells co-transfected with PI3KC2b and HA-proto-Dbl, and immunoprecipitated with anti-Dbl antibody.
doi:10.1371/journal.pone.0044945.g002
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Rho GTPases Activation Assay
NIH3T3-V, -C2b-WT, -C2b-DN cells were grown in 10% FCS
to confluence or they were made quiescent by culturing them in
serum-free medium (0.1%) for 24 h. After starvation they were
stimulated either with 1nm PDGF or 1 mM LPA for 2 min., as
indicated in the figure legends. Afterwards, the cells were washed
with ice-cold PBS supplemented with 1 mM MgCl2 and
immediately lysed in ice-cold Triton 1% lysis buffer (50 mM
Tris-HCl pH 7.5, 1% Triton X-100, 0.5% sodium deoxycholate,
0.1% SDS, 500 mM NaCl, 10 mM MgCl2, 10 mM leupeptin,
10 mM pepstatin and 1 mM PMSF). The cells were rapidly
scraped off the plates and the crude lysates were transferred to pre-
chilled Eppendorf tubes and centrifuged at 16,0606g for 5 min. at
4uC. Protein concentration was determined (Bradford assay,
Pierce) and equal amounts of lysates were immediately supple-
mented with GST-PAK-CRIB or GST-rhotekin for detection of
activated Rac1 and RhoA, respectively. GST-fusion protein (20–
30 mg) on glutathione beads was added to the supernatants and the
tubes were incubated with constant rotation at 4uC for 30 min.
The beads were thereafter washed 4x with ice-cold washing buffer
(50 mM Tris-HCl pH 7.5, 1% Triton X-100, 150 mM NaCl,
10 mM MgCl2, mM leupeptin, 10 mM pepstatin and 1 mM
PMSF). SDS-PAGE sample buffer was added. Samples were
heated at 95uC for 3 min. and subjected to SDS-PAGE and
western blot analysis.
GEF Activity Aassays
HEK293 cells were transiently transfected with plasmids as
described above. Cell lystaes were prepared as above and
immunoprecipitated with anti-Dbl antibodies and Protein A-
Sepharose beads. The immunoprecipitates were washed twice
with lysis buffer and once with GEF reaction buffer (20 mM Tris-
HCl pH 7.6, 0.5% Triton X-100, 100 mM NaCl, 10 mM MgCl2,
1 mM DTT) and resuspended in GEF reaction buffer on ice. The
Figure 3. Kinase-dependent PI3KC2b effect on cytoskeletal rearrangements. (A) Cell lysates of NIH3T3 cells stably expressing empty vector
(NIH3T3-V), kinase-dead (D1213A) dominant-negative Myc-PI3KC2b (NIH3T3-C2b-DN) and wild-type Glu-PI3KC2b (NIH3T3-C2b-WT) were analysed for
the recombinant PI3KC2b expression by immunoblotting with the indicated antibodies (EE: Glu-tag, 9E10: Myc-tag). (B) Confocal images of NIH3T3-V,
-C2b-WT and –C2b-DN cells grown on cover slips for 24 h in 10% FCS and stained with Alexa Fluor 555 dye to localise F-actin, and an anti-PI3KC2b
antibody follwed by FITC-labelled anti-rabbit antibody, to localize the kinase. WT1, WT2 and DN1, DN2 indicate individual clones. Scale bar represents
40 mm.
doi:10.1371/journal.pone.0044945.g003
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reaction was started by the addition of 1 mM GTPcS and 50 mg/
ml purified recombinant RhoA and incubated for 30 min at room
temperature. The samples were then placed on ice and
supernatants collected. Active RhoA was isolated from the
supernatants by using GST-rhotekin, as described above and
samples were analysed by SDS-PAGE and western blot.
Pull-down Assays for PI3KC2b/Dbl/Grb2 Interaction
After 48 h of culture in 10% FCS medium, untransfected and
transfected with HA-proto-Dbl or pcDNA3 empty vector
HEK293 cells were washed with ice-cold PBS and lysed on ice
for 20 min. in Triton 1% (50 mM Tris-HCl pH 7.5, 150 mM
NaCl, 1 mM EDTA, 0.5 mM EGTA, 1% Triton X-100, 0.5%
NP-40, 1 mM DTT added before use) lysis buffer supplemented
with 76concentrated stock of protease inhibitors (Complete Mini,
Roche) and phosphatase inhibitors (1 mM NaF, 1 mM Na3VO4
and 10 mM b-glycerophosphate). The crude lysates were centri-
fuged at 16,0006g for 25 min. at 4uC. Protein concentration was
determined (BCA, Pierce) and equal amounts of lysates were
immediately supplemented with GST-NT-C2b, GST-(CT)C2-
C2b or GST-Grb2 immobilized on gluthatione beads. The tubes
were incubated with constant rotation for 2 h at 4uC. The beads
were thereafter washed four times with ice-cold lysis buffer. SDS-
PAGE sample buffer was added. The samples were heated at 95uC
for 3 min. and subjected to SDS-PAGE and western blot analysis
for detection of interaction with Dbl.
In the case of Dbl domains interaction with PI3KC2b, COS-1
cells were co-transfected with wild-type PI3KC2b and GST-
tagged Dbl domains (NT-, spectrin-, onco-, PH) or pcDNA3
epmty vector and HA-proto-Dbl as control. 48 h post-transfection
cells were washed with ice-cold PBS and lysed on ice for 20 min.
in Triton 1% lysis buffer supplemented with protease and
phosphatase inhibitors (as described above). The crude lysates
were centrifuged at 16,0006g for 25 min. at 4uC. Protein
concentration was determined (BCA, Pierce) and equal amounts
of lysates were supplemented with gluthatione-sepharose beads
(GE Healthcare). The tubes were incubated with constant rotation
for 2 h at 4uC. The beads were thereafter washed four times with
ice-cold lysis buffer. SDS-PAGE sample buffer was added. The
samples were heated at 95uC for 3 min. and subjected to SDS-
PAGE and western blot analysis.
Figure 4. PI3KC2b regulates RhoA and Rac1 activity. (A) PI3KC2b
up-regulates RhoA activity. NIH3T3-V, -C2b-DN and –C2b–WT cells were
grown in 10% FCS or serum-starved for 24 h and stimulated with 1 mM
LPA for 2 min. Cell lysates were equalized for protein content and
subjected to GST-rhotekin pull-down as measure of RhoA activity. GTP-
bound and total RhoA were detected with an anti-RhoA antibody. (B)
PI3KC2b mediates RhoA-dependent serum response factor (SRF)
activation. NIH3T3-V, -C2b-DN and -C2b-WT cells were transiently
transfected with the SRF luciferase reporter plasmid p3DA-Luc and pRL-
TK control construct. Cells were maintained in 0.5% FCS for 24 h prior to
stimulation with 15% FCS for 7 h. Luciferase activity was normalized to
pRL-TK control. Figure shows mean 6 SD of three independent
experiments. (C) PI3KC2b up-regulates Rac1 activity. NIH3T3-V, -C2b-DN
and -C2b-WT cells were grown in 10% FCS. Cell lysates were equalized
for protein content and subjected to GST-PAK CRIB pull-down as
measure of Rac-1 activity. GTP-bound and total Rac1 were detected
with anti-Rac1 antibody. Densitometry was performed and signal
intensities were normalized against total Rac1. Data are mean with SD
from two independent experiments. *, p,0.05. (D) PI3KC2b mediates
Rac1-dependent platelet derived growth factor (PDGF) activation.
NIH3T3-V, -C2b-DN and -C2b-WT cells were serum-starved for 24 h
and stimulated with 1 nM PDGF for 2 min. Cell lysates were equalized
for protein content and subjected to GST-PAK CRIB pull-down as
measure of Rac-1 activity. GTP-bound and total Rac1 were detected
with anti-Rac1 antibody. Densitometry was performed and signal
intensities were normalized against total Rac1. Data are mean with SD
from two independent experiments. *, p,0.05. A representative
western blot is shown. Activation of JNK was assessed in the cell lines
treated with PDGF by immunoblotting with phospho-specific SAPK/JNK
antibody. WT1, WT2 and DN1-3 indicate individual clones.
doi:10.1371/journal.pone.0044945.g004
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In Vitro Binding Assay
To test the PI3KC2b association to Dbl spectrin- and PH-
domains an in vitro binding assay, which utilized GST-tagged Dbl
spectrin- and PH- domains and GST alone immobilized on
gluthatione-speharose beads was performed. Immobilized proteins
were incubated in vitro with soluble Grb2- and NT-C2b- domain in
1% Brij 96 (50 mM Tris.Cl pH 7.4, 150 mM NaCl, 1 mM
EDTA, 0.5 mM EGTA, 1% Brij96) lysis buffer supplemented with
76concentrated stock of protease (Complete Mini, Roche) and
phosphatase inhibitors (1 mM sodium fluoride, 1 mM sodium
orthovanadate, 10 mM b-glycerophosphate). Soluble Grb2- and
NT-C2b-domain were obtained from GST-fused Grb2 and GST-
N-terminal PI3KC2b domain as a result of digestion with
thrombin. Following constant rotation for 2 h, at 4uC, the
complexes were washed 3x with Brij 96 1% lysis buffer. SDS-
PAGE sample buffer was added and the samples were heated at
95uC for 5 min. and subjected to SDS-PAGE followed by western
blot analysis.
Cell Proliferation
Cell counting experiments based on Trypan Blue exclusion
were performed. NIH3T3-V, -C2b-WT, -C2b-DN cells were
grown in 12-well plates at a density 20 cells/ml in the presence of
either 10% or 0.5% FCS. After 48 h cells were washed once with
phosphate-buffered saline (PBS) and trypsinized. When needed
clumps within the cell suspension were disaggregated by passing
the well content 5 times through a 20-gauge needle and the
number of viable cells was determined by Trypan Blue exclusion,
using a haemocytometer. Experiment was performed in triplicate.
Wound Healing Assay
For wound healing assays, NIH3T3-V, -C2b-WT, -C2b-DN
cells were plated in 12-well culture plates in complete medium and
grown to confluency. Where indicated, confluent cells were serum-
deprived overnight and treated with 10 nM PDGF. A wound was
done by making a scratch on the cells monolayer with a 200 ml tip.
The migration rate was monitored for 16 h by phase contrast
microscopy (Leica DM IRBE Inverse, Widefield) equipped with a
temperature controller. The wounded cell monolayers were
photographed and quantitative analysis was prepared for each
experiment. The wounded area was defined in each image by
positioning lines in correspondence of the original scratch and
wound closure distance was analysed by micrometer measure-
ments.
Cell Death (Anoikis) Assay
NIH3T3-V, NIH3T3-C2b-WT, NIH3T3-C2b-DN cells or
NIH3T3 and NIH3T3-C2b-WT cells transiently transfected
(Lipofectamine, Invitrogen) with pcDNA3 empty vector,
PI3KC2b-WT, constitutively active or dominant-negative form
Figure 5. The assembly of the Dbl - PI3KC2b complex is not modulated by PI3K activity or cell stimulation with EGF or PDGF. (A)
HEK293 cells were transfected with vectors encoding Dbl in combination with Myc-PI3KC2b WT or DN, or empty vector. Immunoprecipitates
prepared with anti-Dbl or anti-Myc tag antibodies were analysed by western blot with the antibodies indicated. (B) Lysates from NIH3T3-V, -C2b-WT
or -C2b-DN cells were immunoprecipitated with anti-Dbl antibodies and analysed by western blot. (C) Serum-starved NIH3T3-C2b-WT cells were
stimulated with EGF (20 ng/ml) or PDGF (20 ng/ml) for the indicated lengths of time. Immunoprecipitates prepared with anti-Glu (EE) tag antibodies
were analysed by western blot with the antibodies indicated. (D) HEK293 cells were transfected with vectors encoding Dbl in combination with Myc-
PI3KC2b WT or DN, or empty vector. Immunoprecipitates prepared with anti-Dbl antibodies were analysed for GEF activity towards recombinant
RhoA.
doi:10.1371/journal.pone.0044945.g005
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of GFP-fused RhoA and myristylated Akt were used. Cells were
grown for 48 h in attachment then trypsinized and washed once
with DMEM/10% FCS. The cells were then placed in Ultralow
attachment 96-well plates (Corning) at 26105 cells/well in 100 ml
DMEM containing 10% FCS at 37u/5% CO2. After 16 h
detachment-induced apoptosis was analysed based on the caspase
3/7 activation using the Caspase-Glo 3/7 Assay (Promega),
according to manufacturer’s instruction.
Immunofluorescence
Cells were seeded on glass coverslips and grown for 48 h.
Coverslips were rinsed in PBS and fixed with 4% paraformalde-
hyde. Prior to permeabilisation with 0.2% Triton X-100, cells
were incubated with 0.1M glycine. After blocking in 2% horse-
serum immunostaining was performed with an anti-PI3KC2b
antibody followed by FITC-conjugated goat anti-rabbit antibody
and Alexa Fluor 555 conjugated phalloidin (Invitrogen). Cover-
slips were mounted in Mowiol (Centre for Microscopy and Image
Analysis, Zurich) and cells were examined by confocal laser
scanning microscopy (Leica SP1, Centre for Microscopy and
Image Analysis, Zurich).
Luciferase Reporter Assays
Transient transfections of NIH3T3 cells were carried out using
Lipofectamine (Invitrogen) according to the manufacturer’s
protocol. Around 56104 cells per well in 12-well plate format
were transfected with 25 ng of p3DA-Luc and 50 ng of pRL-TK
(Promega, Madison, WI). After transfection cells were maintained
in 0.5% FCS for 24 h before stimulation with 15% serum for
seven hours. Firefly luciferase activity was normalized to pRL-TK
luciferase activity. Figures show mean 6 SD of three independent
experiments.
Statistical Analysis
Analysis of variance and Bonferroni multiple comparison test or
Kruskal-Wallis non-parametric analysis of variance test were used
to assess statistical significance of differences between groups. P
values ,0.05 were considered as significant.
Results
PI3KC2b Interacts with Dbl
The small GTPases Rac and RhoA are regulated by proteins
modulating their GTPase activity. We and others reported the
interaction of PI3KC2b with RhoGEFs such as Eps8 and
intersectin [17,40]. To elucidate the molecular mechanism of
PI3KC2b–dependent Rac and RhoA activation in NIH3T3 cells,
we investigated the binding of PI3KC2b to a panel of RhoGEFs
family members. We performed co-immunoprecipitation studies
using an anti-PI3KC2b and an anti-epitope-Glu-tag (EE) antibody
Figure 6. PI3KC2b protects NIH3T3 cells against anoikis. (A)
NIH3T3-V, -C2b-DN and -C2b-WT cells were plated in presence of serum
on ultra-low attachment matrix. After 16 h Caspase 3/7 activity was
measured as readout for detachment-induced apoptosis (anoikis). Data
are mean 6 SD of two independent experiments. WT1, 22 and DN1,
22 indicate individual clones. (B) NIH3T3 cells transiently transfected
with the wild-type Myc-PI3KC2b, constitutively active form of GFP-fused
RhoA protein (CA-RhoA-GFP) or myristylated (Akt-myr) were plated 48 h
post-transfection on ultra-low attachment matrix. 16 h later Caspase 3/
7 activation was analysed as readout for anoikis. Data are mean6 SD of
three independent experiments. Expression level of the transfected
proteins and associated signalling was analysed 48 h post-transfection
by immunoblotting with indicated antibodies. (C) NIH3T3-C2b-WT cells
were transiently transfected with dominant-negative RhoA-GFP (DN-
Rho-GFP) or control vector (V). 48 h post-transfection cells were plated
on ultra-low attachment matrix and caspase 3/7 activation was
measured. Data are mean 6 SD of three independent experiments.
48 h post-transfection expression level of the transfected proteins was
analysed by western blot with indicated antibodies.
doi:10.1371/journal.pone.0044945.g006
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with lysates of NIH3T3 cells stably expressing Glu-tagged wild-
type (WT) PI3KC2b form. As shown in Fig. 1A, we detected a
binding of the recombinant PI3KC2b with endogenously
expressed RhoGEF Dbl, which belong to one of the best studied
regulators of RhoGTPases [36]. Our further analysis showed that
PI3KC2b co-immunoprecipitated Grb2 and Src (Fig. 1A). Grb2
has been reported to serve as an adaptor protein for PI3KC2b
downstream of the EGFR in HEK293 cells [12], whereas Src is
involved in EGFR and PDGFR downstream signalling in
NIH3T3 fibroblasts [41]. The results revealed an endogenous
PI3KC2b/Dbl complex in the NIH3T3 parental cell line (Fig. 1B).
To confirm our findings, we selected IMR5, a neuroblastoma
cancer cell line, which expresses relatively high levels of PI3KC2b
and Dbl, and performed co-immunoprecipitation with anti-Dbl
and anti-PI3KC2b antibodies. As depicted in Figure 1B,
PI3KC2b associated with Dbl in the IMR5 cells confirming the
formation of an endogenous protein complex. We were further
interested in studying the molecular mechanism of PI3KC2b/Dbl
complex assembly. Pull down experiments with GST-fused
PI3KC2b N-terminal and C2 C-terminal domain and lysates of
HEK293 cells transfected with HA-tagged proto-Dbl revealed that
the N-terminal sequence of the PI3K is involved in the interaction
with Dbl (Fig. 1C). The N terminus of PI3KC2b (in particular
proline-rich regions) was previously shown to mediate PI3KC2b
association with the activated EGF receptor through the Grb2
adaptor protein [12]. Interestingly, our pull down experiments
with purified GST-fused Grb2 and lysates of HEK293 cells
transfected with HA-tagged proto-Dbl showed binding of Grb2 to
Dbl, and confirmed the interaction with PI3KC2b (Fig. 1D).
Additionaly, Grb2 complex formation with endogenous Dbl was
detected in untransfected HEK293 cells, which confirms the
relevance of this interaction. These findings demonstrate the
formation of a multi-protein complex comprising PI3KC2b, Grb2
and Dbl, which may be functional in normal cells (NIH3T3), as
well as in cancer cells (IMR5). Whether the protein-protein
interactions in this complex are direct or mediated by other
possible interaction partners was further elucidated in an in vitro
binding assay.
Dbl RhoGEF Domains Bind to PI3KC2b with Different
Affinities
Considering the multi-domain structure of Dbl, we were
interested in uncovering which part of the protein sequence is
involved in the interaction with PI3KC2b. Pull down experiments
with glutathione-sepharose beads from COS-1 cells co-transfected
with GST-fused Dbl N-terminal-, spectrin-, onco-, PH- mutants
and wild-type PI3KC2b showed a prominent interaction of the
kinase with the Dbl spectrin- and PH- domain (Fig. 2). On the
other hand, none of the Dbl domains bound to Grb2, whereas
Grb2 associated with full-length HA-proto-Dbl immunoprecipi-
tated with anti-Dbl antibody and immobilized on beads. The N-
terminal spectrin- and C-terminal PH- domain of Dbl were
previously shown to associate with the chaperone Hsc70. This
interaction results in Dbl adopting an inactive conformation,
which in turn blocks an access of GTPases to its DH- catalytic
domain [31,33]. Furthermore, it was suggested that the spectrin
domain regulates the level, localization, and activity of proto-Dbl
through the interaction with Hsc70-Hsp90 and the ubiquitin ligase
CHIP [32]. However, further investigations are required to exactly
assess the contribution of PI3KC2b to the regulation of Dbl
activity.
The binding of Dbl spectrin and PH domains to PI3KC2b in
co-transfected COS-1 cells led us to test whether this interaction is
direct. Therefore, an in vitro binding assay was performed, which
Figure 7. PI3KC2b increases MAPK and Akt signalling down-
stream of EGFR and PDGFR. (A) and (B) NIH3T3-V, -C2b-DN and -
C2b-WT cells were serum-deprived overnight and stimulated for
10 min. with EGF (A) or PDGF (B) as indicated. Cell lysates were
analysed by immunobloting and MAPK and Akt pathway activation was
assessed with indicated phospho-specific antibodies. (C) and (D) Lysates
of NIH3T3-V, -C2b-DN and -C2b-WT cells grown in 10% FCS were
analysed for activated signalling molecules implicated in the cell cycle
control and caveolae formation such as p53, Bcl2, PTEN and caveolin 1,
22. WT1, 22 and DN1, 22 indicate individual clones.
doi:10.1371/journal.pone.0044945.g007
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used recombinant GST-tagged spectrin- and PH- Dbl domains
immobilized on gluthatione-sepharose beads together with the
soluble N-terminal region of PI3KC2bor/and Grb2– expressed
and purified in E.coli (Fig. S1). In the case of NT-PI3KC2b, we did
not observe an interaction with Dbl. On the other hand, Grb2
showed an interaction, but due to detectable binding with GST
control, we considered it as un-specific. The lack of association of
the NT-PI3KC2b and Grb2 with Dbl domains suggests that other
factors are required for the interaction in living cells (Fig. S1).
Overexpression of PI3KC2b is Sufficient to Induce Cell
Morphology Changes in a Kinase-dependent Manner
We and others have reported that PI3KC2b interacts with
different receptor tyrosine kinases such as EGFR, PDGFR and c-
Kit [9,10,12]. We aimed to investigate the biological importance
of PI3KC2b in NIH3T3 mouse fibroblast cells. Since these cells
have very low levels of endogenous PI3KC2b expression, we
established NIH3T3 clones stably expressing an epitope wild-type
(WT) and a mutant kinase-dead (DN) PI3KC2b form. NIH3T3
cells stably transfected with an empty pBabeNeo vector were used
as control. We utilised a mutant that we previously reported to
eliminate PI3KC2b-associated lipid kinase activity by mutation of
the highly conserved aspartate (DFG) to an alanine residue in the
activation domain (D1213A, PI3KC2b-DN) [17].
Western blot analysis confirmed the expression of each of the
constructs (Fig. 3A). For further experiments clones with high
recombinant protein expression were selected. Interestingly, we
observed striking morphological differences between the cell clones
differentially expressing either the WT or DN PI3KC2b. In
comparison to control cells, NIH3T3-C2b-WT cells displayed
increased cell spreading with strong stress fibres assembly and
increased membrane ruffling revealed by F-actin staining (Fig. 3B),
whereas the clones expressing the kinase-dead form of PI3KC2b
did not display F-actin polymerisation and presented rounded
phenotype with a strongly reduced cell spreading (Fig. 3B).
Staining for PI3KC2b showed cytosolic distribution with addi-
tional localisation of the protein to cell extensions and cell-cell
contacts (Fig. 3B). Stimulation with PDGF led to more
pronounced membrane localisation of PI3KC2b protein in
NIH3T3-C2b-WT cells (data not shown), revealing recruitment
to the activated PDGF receptor in the cell membrane as reported
[9]. In line with our previous report [17], these data demonstrate
that the lipid kinase activity of PI3KC2b plays a role in
modulating the actin cytoskeleton in NIH3T3 cells.
PI3KC2b Regulates Rac and RhoA Activity
Due to the observation, that NIH3T3-C2b-WT cells show
increased spreading and membrane ruffling, two phenotypes
related to the small GTPases RhoA and Rac1 [24], we analysed
RhoA activity in serum-supplemented conditions and found highly
elevated basal levels of GTP-loaded RhoA in NIH3T3-C2b-WT
cells in comparison to control cells (Fig. 4A). Based on recent
observation that PI3KC2b modulates cell migration in response to
lysophosphatidic acid (LPA) [16], we treated serum-starved cells
with LPA, a commonly used RhoA activator [42]. NIH3T3-C2b-
WT cells showed increased RhoA activation, but also higher basal
activity in low serum, compared to control cells (Fig. 4A).
NIH3T3-C2b-DN cells displayed only a minimal response to
LPA treatment (Fig. 4A). To confirm these observations we used a
different approach, making use of the fact that RhoA activates a
MADS-Box transcription factor termed serum response factor
(SRF) [43]. SRF controls growth factor regulated immediate-early
genes such as c-fos and cytoskeletal actin [44]. RhoA downstream
targets such as mDia and LIM kinase 1 effectively regulate SRF by
modulating the activity of a SRF co-factor termed MAL [45].
MAL is constitutively bound to monomeric actin and thus
sequestered in the cytosol. Activation of RhoA in response to
serum leads to actin polymerisation, MAL release from G-actin
and its translocation to the nucleus, where it binds and activates
SRF [45]. In a transactivation luciferase assay we determined up
to 5-fold MAL-dependent SRF response in NIH3T3-C2b-WT
cells after serum stimulation as compared to control cells (Fig. 4B).
In contrast, NIH3T3-C2b-DN cells showed only minimal SRF
activation (Fig. 4B).
We next analysed Rac activity in serum-supplemented condi-
tions. NIH3T3-C2b-WT cells showed significantly elevated Rac
GTP loading, whereas the three DN clones tested had reduced
Rac activity compared to control cells (Fig. 4C). Next we
investigated Rac activation downstream of the PDGFR. We
found strongly increased Rac GTP levels upon PDGF stimulation
in NIH3T3-C2b-WT cells compared to control cells (Fig. 4D).
Phosphorylation of the downstream Rac target SAPK/JNK was
strongly elevated as well (Fig. 4D). Interestingly, in NIH3T3-C2b-
DN we observed down to 50% reduced Rac activation and
accordingly very weak SAPK/JNK phosphorylation (Fig. 4D).
Taken together, these results indicate that PI3KC2b is implicated
in the LPA and serum dependent activation of RhoA and in the
Rac activation upon PDGF treatment.
The Assembly of the Dbl - PI3KC2b Complex is not
Modulated by PI3K Activity or Cell Stimulation with EGF
or PDGF
The data presented above suggested that the catalytic activity of
PI3KC2b may modulate activation of Rho/Rac proteins via Dbl.
In order to further investigate the importance of PI3KC2b kinase
activity for its interaction with Dbl, we assessed the ability of
PI3KC2b WT and DN to interact with Dbl in transiently
transfected HEK293 cells and stably transfected NIH3T3 cells. In
HEK293 cells, both PI3KC2b WT and DN interacted with
endogenous or ectopically expressed (HA-tag) Dbl in a similar
manner (Fig. 5A). This observation was confirmed in NIH3T3-
C2b-WT and NIH3T3-C2b-DN cells (Fig. 5B).
We next assessed whether the Dbl - PI3KC2b complex was
constitutively assembled, or induced by cell stimulation with
polypeptide growth factors. The Dbl - PI3KC2b complex could be
detected in serum-starved NIH3T3-C2b-WT cells, and the
interaction was apparently not increased by cell stimulation with
EGF or PDGF from 59 up to 309 (Fig. 5C).
Finally, we investigated whether the catalytic activity of
PI3KC2b contributes to the activation of Dbl GEF activity. In
transiently transfected HEK293 cells, ectopic expression of
PI3KC2bWT or DN did not alter the GEF activity of endogenous
Dbl towards RhoA (Fig. 5D). Taken together, these results indicate
that PI3KC2b lipid kinase activity is not required for its
association with Dbl, and does not modulate Dbl activity
measured in vitro.
PI3KC2b Protects NIH3T3 Cells from Detachment-
induced Death (Anoikis)
Forkhead fox O (FOXO) family of transcription factors have
been reported to control the expression of caveolin-1 [46].
Phosphorylated FOXO remains in the cytosol [47] and is not
able to activate Caveolin 1 transcription. Based on these reports
we investigated Caveolin 1 and 2 expression and found strong
protein downregulation of both proteins (Fig. 6D). These two
isoforms are crucial for the proper formation and function of
caveolae: membrane invaginations serving as signalling platforms
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on the cell surface and are often disassembled in cancer cells [48].
Caveolin 1 deleted cells become resistant to detachment-induced
death [49] and caveolin 1 deletion is sufficient to drive cell
transformation in NIH3T3 cells [50]. Interestingly, in NIH3T3-
C2b-DN cells we observed strongly reduced matrix attachment to
collagen and fibronectin and loss of contact inhibition, thus
NIH3T3-C2b-DN cells were able to proliferate in multi-layers
after reaching confluence without undergoing apoptosis (data not
shown). Surprisingly, we found that p53 was strongly elevated in
these cells (Fig. 6D). However the anti-apoptotic Bcl-2 protein
showed also strongly increased expression (Fig. 6D). These protein
deregulations revealed a pattern reported for cells protected from
anoikis [51]. We analysed cell death induction by plating the cells
on ultra-low attachment matrix. After 16 h incubation NIH3T3-
C2b-DN cells showed very robust apoptosis protection measured
by Caspase 3/7 activation, nevertheless the NIH3T3-C2b-WT
cells had also lower apoptosis induction compared to control cells
(Fig. 7A). Since inhibition of RhoA results in loss of substrate
adhesion and severe cell retraction [24], we hypothesised that due
to the long lasting clonal selection, cells with high kinase-dead
PI3KC2b expression and hence attenuated RhoA function will
gain survival advantage only under conditions when are able to
upregulate signalling pathways protecting them from the RhoA-
dependent lost of cell anchorage and the following apoptosis
induction.
We reported that PI3KC2b protects A-431 epithelial carcinoma
cells from anoikis, however the mechanism remain elusive [17]. To
test the hypothesis that wild-type PI3KC2b protects cells from
anoikis in a RhoA dependent manner, we performed transiently
expression of wild-type PI3KC2b, constitutively active RhoA and
myristoylated Akt as a positive control in NIH3T3 cells. All three
proteins were able to decrease significantly Caspase 3/7 activation
in cells plated on ultra-low attachmentmatrix for 16 h, compared to
NIH3T3 cells transfected with an empty vector (Fig. 7B). Moreover,
transient transfection of NIH3T3-C2b-WT cells with a dominant-
negative RhoA construct led to an increase in apoptosis induction
compared to parental cells (Fig. 7C). These findings reveal an
important role of PI3KC2b in protecting cells from detachment-
induced apoptosis in a RhoA-dependent manner.
PI3KC2b Expression Increases the Activation of EGFR and
PDGFR Downstream Signalling
The recruitment and activation of PI3KC2b downstream of the
EGFR and the PDGFR has been reported [9,12]. In agreement
with these reports, the results discussed above pointed to a
PDGFR related PI3KC2b function in cell migratory responses.
Therefore, we aimed to investigate Akt and Erk signalling pathway
activation downstream of these two receptors. In line to our
previous findings [10], elevated expression of wild-type PI3KC2b
increased Akt pathway activation upon EGF and PDGF
treatment, illustrated by increase in serine and threonine Akt
phosphorylation, FOXO and S6 protein phosphorylation (Fig. 6A
and B). Moreover, the extracellular regulated kinase (Erk1) showed
also increased phosphorylation, compared to control cells.
Surprisingly, we found very high basal Akt and FOXO
phosphorylation levels in NIH3T3-C2b-DN cells. Moreover,
EGF or PDGF stimulation did not further increase the Akt and
FOXO phosphorylation (Fig. 6A and B). On the contrary, Erk
activation was strongly abolished in these cells and the response to
PDGF was clearly weaker than to EGF (Fig. 6A and B).
In order to understand how these signalling differences
contribute to the observed cytoskeletal rearrangements, we further
studied signalling in cells grown in serum-supplemented condi-
tions. Very high basal Akt and FOXO phosphorylation was
detected in the NIH3T3-C2b-DN cells, however we did not find
any striking differences in Akt and FOXO phosphorylation
between NIH3T3-C2b-WT and control cells (Fig. 6C). Also the
expression of the negative regulator of PI3K signalling PTEN was
not consistently decreased in the NIH3T3-C2b-DN cells under
study (Fig. 6D). However, we observed an induction of p53
expression in the NIH3T3-C2b-DN cells (Fig. 6D). In addition
these cells displayed increased Bcl-2 expression and reduced
expression of caveolin-1 and caveolin-2 (Fig. 6D). Thus it appears
that NIH3T3-C2b-DN cells display prominent changes in the
expression of major regulators of apoptosis and tumour suppres-
sors. It is conceivable that enforced expression of dominant
negative PI3KC2b in NIH3T3 cells leads to p53 induction and
anoikis and that the surviving NIH3T3-C2b-DN cells have
managed to escape apoptosis during the selection process by up-
regulating Bcl-2 expression and activating the Akt pathway. The
down-regulation of caveolin expression in NIH3T3-C2b-DN cells
may contribute to the constitutive activation of the Akt pathway,
by relieving an inhibitory effect on RTK signalling. Collectively,
our data reveal the implication of PI3KC2b in the activation of the
EGFR- and PDGFR-dependent Akt and Erk signalling cascades.
PI3KC2b Mediates Migratory Response Downstream of
the PDGFR
Next, we attempted to analyse the migratory properties in
NIH3T3 cells with deregulated PI3KC2b expression. We
performed a wound healing assay under serum-supplemented
conditions and in cells upon PDGF stimulation. Compared to
control cells neither PI3KC2b-WT nor PI3KC2b-DN had a
significant impact on the migratory cell speed in 10% serum (Fig.
S2A). However, when cells were starved for 24 hours and then
PDGF was added, we observed very strong migratory delay down
to 80% in NIH3T3-C2b-DN cells (Fig. S2A). Interestingly,
NIH3T3-C2b-WT cells were also not able to fully respond and
migrated at 60% speed of control cells. These effects were not due
to a different proliferation status, since NIH3T3-C2b-WT cells
showed even slightly increased proliferation in serum. Surprisingly,
NIH3T3-C2b-DN cells showed nearly doubled cell proliferation
in low serum (Fig. S2B). These experiments reveal a PI3KC2b-
dependent migratory response downstream of the activated PDGF
receptor in NIH3T3 cells.
Discussion
Our analysis of the interacting molecules of PI3KC2b in
NIH3T3 fibroblasts revealed a novel signalling complex implicat-
ed in RhoA and Rac1 activation. We identified the RhoGEF Dbl
as a novel interaction partner of PI3KC2b and we hypothesise
that, in collaboration with Dbl, PI3KC2b can modulate RhoA
and Rac1 activity and thus control cytoskeletal rearrangements,
cell motility and protection against anoikis. Dbl is a crucial
RhoGEF with activity towards Cdc42, RhoA and Rac1 [52]. It
was also the first mammalian RhoGEF to be identified [26], but
the mechanism of its activation is still not completely understood.
In order to relieve its intrinsic auto-inhibitory activity, a physical
interaction between the GEF’s N-terminal spectrin- and C-
terminal PH-domain has to be released. This change in the
inactive conformation of the protein can be triggered by diverse
regulatory mechanisms including phosphorylation, or interactions
with some other proteins. In our studies, the prominent binding of
PI3KC2b to the spectrin- and PH- domain of Dbl was similar to
the results reported for Dbl binding to the chaperone Hsc70 [31].
Hsc70 together with Hsp90 and the ubiquitin ligase CHIP keep
Dbl activity in check by stabilising its inactive conformation. An in
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vitro examination of the molecular mechanism of PI3KC2b/Dbl
complex formation, however, revealed that neither the N-terminal
sequence of the PI3K, nor Grb2, directly bound to Dbl, although
both molecules were present in the PI3KC2b complex isolated
from living cells. Formation of the Dbl/PI3KC2b complex was
observed in serum-starved cells and the association was not further
promoted by EGF or PDGF stimulation. In addition, we did not
find evidence for a role of PI3KC2b in the activation of Dbl GEF
activity, at least when measuring its activity in vitro. Therefore,
other molecules need to be present in the cells, which mediate the
interaction of the class II PI3K with Dbl and Dbl activation,
resulting in the observed phenotypes in the NIH3T3 cells. The
identity of these putative additional binding partners involved in
the Dbl/PI3KC2b complex is briefly discussed below.
Grb2 has been reported to be crucial for the EGF-dependent
Dbl phosphorylation and subsequent GEF activation towards
RhoA and Cdc42 [53,54]. These findings support our observation
that Grb2 is present in the Dbl/PI3KC2b complex in NIH3T3
cells. Dbl phosphorylation is catalysed by the non-receptor
tyrosine kinase Ack1 [54], a widely expressed protein which is
recruited and activated downstream of the EGFR and PDGFR via
Grb2 [55]. Furthermore, Dbl binds to newly generated phospho-
inositides (mainly PI(3,4,5)P3 and PI(4,5)P2), via its PH domain
thereby localizing to the plasma membrane [56]. Considering the
potential of Class II PI3K to generate the same spectrum of
phosphoinositides as Class I PI3K [7,9,14], this model provides a
possibility for PI3KC2b to build up a complex consisting of Grb2,
ACK1 and Dbl, which may be important for RhoA and Rac
activation in serum-supplemented conditions and Rac activation
upon EGF or PDGF stimulation. After EGF or PDGF stimulation,
the Dbl/PI3KC2b complex may be recruited to the plasma
membrane via Grb2 and generates PI(3,4,5)P3, which binds to the
PH domain of Dbl. Grb2, on the other hand, may bind to ACK11
complexed with Cdc42. Being in close proximity, ACK1 could
therefore bind to Dbl. Ack1 could phosphorylate Dbl only when in
complex with Grb2 and Cdc42, which then become activated and
in turn activates RhoA and Rac leading to stress fibres and
membrane ruffles formation. Further investigations of the phos-
phorylation status of Dbl in the NIH3T3 cells over-expressing
PI3KC2b are needed to confirm this model.
Surprisingly, the increased basal and PDGF-induced Rac1
activity in NIH3T3 cells expressing wild-type PI3KC2b did not
correspond to increased wound healing properties, a response
which can be explained by the fact that active RhoA and the
generation of focal adhesions and stress fibres significantly slow
down cell migration [57]. NIH3T3 cells transfected with dominant
negative PI3KC2b cells failed to activate Rac1 after PDGF
stimulation. This became more evident when looking at the
completely abolished wound healing properties of the cells after
PDGF treatment, once again confirming the importance of
PI3KC2b-dependent PDGFR signalling. The RhoA-activating
function of PI3KC2b also had inhibitory effects on detachment-
induced apoptosis. We observed this outcome in both NIH3T3
cells stably expressing wild type PI3KC2b and in NIH3T3 cells
transiently transfected with the wild type PI3KC2b. Moreover, in
both systems, caspase activation was reduced down to ,65% of its
original activity after plating the cells under ultra-low attachment
conditions. The same effect was observed after transient overex-
pression of constitutively active RhoA in NIH3T3 cells. These
results are in agreement with a recent report showing that active
RhoA was able to rescue NIH3T3 cells from detachment-induced
apoptosis [58]. This anti-apoptotic effect under stress conditions
could play also a role under normal conditions as we observed
slightly, but significant, increase in cell proliferation in NIH3T3
cells expressing wild type PI3KC2b, compared to control cells.
Even ROCK, a downstream target of RhoA has been widely
accepted as mediator of apoptosis by inducing characteristic
morphological changes, including cell contraction and dynamic
membrane blebbing, RhoA seems to be excluded from this
signalling cascade [59]. Here we provide further evidence that
sustained RhoA activation provides NIH3T3 cells with pro-
survival signals and enables anchorage-independent cell survival,
one of the first phenomenon described for oncogenic Rho proteins
[60].
Together, our data show for the first time that overexpression of
PI3KC2b in NIH3T3 cells is sufficient to induce RhoA and Rac
activation and thus to promote cell transforming properties,
reported for both RhoA and Rac [61,62]. We have further
identified the Dbl RhoGEF as a new interaction partner for
PI3KC2b. Previous reports [10,17] and unpublished observations
have revealed that PI3KC2b is overexpressed in different human
cancer cell lines and primary tumour samples, and modulates cell
survival and chemotherapy resistance [63]. Together with the
present report we propose a model in which PI3KC2b can
contribute to the protection of cells from anoikis and increase
Rho/Rac, Akt and Erk signalling downstream of the EGFR and
PDGFR. This signalling pathway may therefore contribute to the
malignant progression of human cancers.
Supporting Information
Figure S1 PI3KC2b and Grb2 do not associate directly with
Dbl. (A) GST-tagged and gluthatione-sepharose beads conjugated
spectrin- and PH- Dbl domains, and GST as control, were
incubated in vitro with GST-truncated soluble PI3KC2b N-
terminal domain (NT-C2b) (,35 kDa) and Grb2 (26 kDa). To
detect an interaction wih Dbl domains samples were subjected to
immunoblotting with indicated antibodies. Experiment was
repeated four times with similar results, independently of buffer
used for the reaction (Brij96 or Triton 1%). One representative
blot is shown (Brij96 1% used for the incubation). (B) Control in
vitro reactions, which utilized immobilized on gluthatione-sephar-
ose beads GST-tagged NT-C2b domain and Grb2, and GST as
control, were incubated in vitro with GST-truncated soluble NT-
C2b domain (,35 kDa) and Grb2 (26 kDa). Samples were
subjected to SDS-PAGE analysis and the interaction between
NT-C2b and Grb2 was detected with anti-GST antibody by
western blot analysis. (C) Representative immunoblot of Dbl
domains separated on SDS-PAGE and analysed by wester blot
with anti-GST antibody.
(TIF)
Figure S2 PI3KC2b regulates wound healing properties. (A)
Wound healing assay in NIH3T3-V, -C2b-DN and -C2b-WT
cells, which were grown in 10% FCS or were serum-starved over
night and stimulated with 10 nM PDGF. Migration rate was
monitored for 16 h by phase contrast microscopy. Graph presents
quantitative analysis of time-lapse microscopy pictures. Data are
mean6 SD of two independent experiments. (B) Cell proliferation
of NIH3T3-V, -C2b-DN and -C2b-WT cells, which were growing
for 48 h either in 10% or 0.5% FCS was performed. The number
of viable cells was determined based on Trypan Blue exclusion and
cell counting. Data are mean 6 SD of three independent
experiments. *, p,0.05.
(TIF)
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